Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06475807 · ClinicalTrials.gov registry record · NA

Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors

A NA study of Cancer, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06475807 is a NA study of Cancer that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 60 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06475807, a NA study of Cancer, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This pilot trial will study the potential impact of two distinct dietary interventions with sequential use of high-fermented foods and high-fiber supplements on the gut microbiome and antitumor immunity in patients with melanoma and non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors. The trial aims to understand how dietary changes affect the composition and function of the gut microbiome, together with immunological and metabolomic markers in serum in patients with melanoma and NSCLC who are undergoing standard-of-care treatment with a PD-1/PD-L1 Inhibitors (neoadjuvant, adjuvant or consolidation)

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT High-fermented food
  • DIETARY_SUPPLEMENT High fiber supplementation

Study Locations (1)

Pennsylvania

  • UPMC Hillman Cancer Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-07-17
Est. Completion 2027-06
Phase NA

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT06475807

The ClinicalTrials.gov registry entry for NCT06475807 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (98% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which High-fermented food is the first listed.

NCT06475807 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06475807 about?

NCT06475807 is a clinical study titled "Dietary Interventions in Cancer Patients Treated With Immune Checkpoint Inhibitors". This pilot trial will study the potential impact of two distinct dietary interventions with sequential use of high-fermented foods and high-fiber supplements on the gut microbiome and antitumor immunity in patients with melanoma and non-small cell lung cancer (NSCLC) treated with immune checkpoint i...

What is the current status of trial NCT06475807?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-07-17. Estimated completion is 2027-06.

What conditions does trial NCT06475807 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06475807?

The interventions under investigation include: High-fermented food (DIETARY_SUPPLEMENT), High fiber supplementation (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06475807?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06475807 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.